The aim of this programme is to translate evidence-based Personalised Medicine research outcomes to clinical application. To achieve this aim, we:
Determine the cost-effectiveness of known Personalised Medicine tests to study their applicability in Singapore
Investigate new tests or techniques to assess if they have a clinical role
Establish or strengthen prospective disease registries to facilitate genotype-phenotype association studies
Establish a virtuous cycle by transforming clinical research to bedside practice, which in turn provides ideas and orientation to generate more research projects
Tan Tock Seng Hospital recognises that Personalised Medicine is playing an increasingly important role in clinical practice. Therefore, the Personalised Medicine Service was established in June 2015 to provide genetic testing services and individualised treatment.
"All of our research are geared towards translational research in which the respective theme leaders aim to discover new biomarkers, new techniques, drug-gene information, and predictive algorithms for the diseases or fields they specialise in. There are seven research themes supported by the NMRC Centre Grant (CG) from the Ministry of Health for a period of 4 years between 2017 and 2020. The CG grant enables the clinicians and laboratory team to be supported by dedicated research assistants, project managers and research-related support services from the other units at CRIO such as data analysing, writing of project agreements, and quality and safety monitoring."
Adjunct Associate Professor Leong Khai Pang
Overall Principal Investigator